Sort   by:  
 Page size 
UnknownLow Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users.
Not available
S-EPMC4281816 | biostudies-literature
UnknownCD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.
Not available
S-EPMC4211711 | biostudies-literature
UnknownLong-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine.
Not available
S-EPMC8357155 | biostudies-literature
UnknownLymph node T cell responses predict the efficacy of live attenuated SIV vaccines.
Not available
S-EPMC3493820 | biostudies-literature
UnknownA study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.
Not available
S-EPMC5309337 | biostudies-literature
UnknownAnalysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.
Not available
S-EPMC4135964 | biostudies-literature
UnknownA HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals.
Not available
S-EPMC10984077 | biostudies-literature
UnknownPrevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
Not available
S-EPMC5909823 | biostudies-literature
UnknownIncreased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.
Not available
S-EPMC3551291 | biostudies-literature
UnknownComprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.
Not available
S-EPMC4315437 | biostudies-literature
Sort   by:  
 Page size